C. pneumoniae serostatus influences cytokine production patterns in steroid resistant and sensitive asthmatics

D. Paróczai (Deszk, Hungary), T. Mosolygó (Szeged, Hungary), D. Kókai (Szeged, Hungary), I. Lantos (Szeged, Hungary), D. Virok (Szeged, Hungary), Z. Rózsavölgyi (Deszk, Hungary), R. Pálföldi (Deszk, Hungary), A. Somfay (Deszk, Hungary), K. Burián (Szeged, Hungary)

Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Paróczai (Deszk, Hungary), T. Mosolygó (Szeged, Hungary), D. Kókai (Szeged, Hungary), I. Lantos (Szeged, Hungary), D. Virok (Szeged, Hungary), Z. Rózsavölgyi (Deszk, Hungary), R. Pálföldi (Deszk, Hungary), A. Somfay (Deszk, Hungary), K. Burián (Szeged, Hungary). C. pneumoniae serostatus influences cytokine production patterns in steroid resistant and sensitive asthmatics. 4395

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased Th2 response with C. pneumoniae infection
Source: Eur Respir J 2002; 20: Suppl. 38, 311s
Year: 2002

Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008

Streptococcus pneumoniae augments inflammatory process in asthma model without changing Th2 profile
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells
Source: Eur Respir J 2011; 37: 53-64
Year: 2011



C. pneumoniae alters CD80 expression in monocytes: implications in asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 30s
Year: 2002

Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma
Source: Eur Respir J 2002; 20: 834-840
Year: 2002



Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae
Source: Eur Respir J 2002; 19: 546-556
Year: 2002



Chlamydia pneumoniae persists in COPD lung tissue: predominant role of toll-like receptor 2 versus 4 in chlamydia pneumoniae-induced activation of pulmonary immune cells
Source: Eur Respir J 2004; 24: Suppl. 48, 240s
Year: 2004

Chlamydia pneumoniae infection in asthmatic patients
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009

The commensal bacterium Rothia mucilaginosa has anti-inflammatory properties in vitro and in vivo, and negatively correlates with sputum pro-inflammatory markers in chronic airway disease.
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021


Prevalence of specific IgE antibodies against Mycoplasma pneumoniae and Chlamydia pneumoniae in extrinsic and intrinsic bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 141s
Year: 2001

In COPD moxifloxacin enhances th1-immune response in the presence of bacterial endotoxin by inducing IL-2 expression
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009

The balance of pro- and anti - inflammatory cytokines in Chlamydia pneumoniae infected cells as a marker of inflammatory activity in the pulmonary compartment
Source: Eur Respir J 2001; 18: Suppl. 33, 154s
Year: 2001

LSC Abstract – The host genetic background impacts on pseudomonas aeruginosa-induced T cell responses and individual susceptibility/resistance to respiratory infection
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015

Treatment of patients with bronchial asthma and latent chlamydophila pneumoniae and mycoplasma pneumoniae infections by a doxycycline
Source: Eur Respir J 2002; 20: Suppl. 38, 159s
Year: 2002

Seroprevalance of chlamydia pneumoniae infection in patients with chronic stable asthma as well as its correlation with high eosinophil cationic protein level
Source: Eur Respir J 2004; 24: Suppl. 48, 590s
Year: 2004

The effect of chlamydia pneumoniae infection on the course of bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 516s
Year: 2003

Gender differences in ecg-QT interval variables during macrolide treatment of mycoplasma pneumoniae infection in children
Source: Eur Respir J 2006; 28: Suppl. 50, 489s
Year: 2006

Chlamydia pneumoniae infection in patients with mild asthma
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011

The role of Chlamydia pneumoniae infection in bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 681s
Year: 2005